Guide

Dual Sourcing Assurance Checklist: Aluminum Component Compatibility, Compliance, and Continuity

Use this six-criteria framework to systematically assess aluminum seal alternatives — from EN ISO 8872 material compliance and residual seal force (RSF) to RTU/RFS/RTP format availability and multi-site supply resilience — and build a dual sourcing strategy that protects fill-finish continuity and patient safety.

Status Published
Format Guide
Language English
Access Registration Required
Resource Overview

About this Checklist

As global supply chains face increasing pressure from geopolitical instability, tariff uncertainty, and capacity constraints, pharmaceutical manufacturers must qualify interchangeable aluminum seal suppliers without accepting performance trade-offs in their injectable drug packaging programs. This strategic checklist provides a structured, six-criteria evaluation framework covering material compatibility and regulatory compliance per EN ISO 8872, EN 573, ISO 9001, ISO 14001, and ISO 15378; functional performance and machinability on high-speed fill-finish lines at 250–400 vials per minute; dual sourcing interchangeability and plug-and-play compatibility without equipment modification; sterility and contamination control across RTU, RFS, and RTP formats with validated gamma sterilization; customization and anti-counterfeit measures aligned to USP <1>; and supply chain resilience backed by regional manufacturing, container closure integrity (CCI) testing, and residual seal force (RSF) qualification support. PrimeCaps™ are referenced throughout as the benchmark solution, with 40 standard plastic disc colors, five aluminum finishes, and validated CCI match to Datwyler's elastomer portfolio.
Access This Resource

Download the Guide

Continue to access the full resource.

Access the Guide
Quick access in under 30 seconds.
TECHNICAL RESOURCES

Stay informed on Datwyler Healthcare technical resources

Subscribe to receive updates on webinars, white papers, technical articles, brochures, and expert insights from our team.